Gelonghui, February 6?Tonghua Dongbao (600867.SH) released its 2022 results of KuaiBao, with operating income of 2.775 billion yuan, down 15.09% from the same period last year; net profit of shareholders belonging to listed companies was 1.589 billion yuan, up 21.46% from the same period last year; net profit of shareholders of listed companies after deducting non-recurring profits and losses was 846 million yuan, down 23.45% from the same period last year; and basic earnings per share was 0.80 yuan.
The main factors affecting business income: since May 2022, the national special collection of insulin has landed in various provinces and cities one after another, and the prices of each series of insulin products of the company have decreased in varying degrees compared with those before collection, and some areas have been affected by the epidemic. It directly leads to a corresponding decrease in business income in the reporting period.
Due to the landing of insulin collection, the company sterilized or returned the difference between the original supply price and the implementation price of insulin products that existed in circulation before the implementation of insulin collection, and the company's operating income decreased greatly due to the impact of this one-time adjustment.
At the same time, with its sound business strategy, reasonable strategic arrangement and strong commercialization ability, the sales volume of all series of insulin products has achieved strong growth, driving the company's product market share to continue to rise. the increase in product sales has greatly offset the impact of the decline in revenue brought about by insulin collection and landing.
The main factors affecting net profit and deducting non-net profit: during the reporting period, in order to invigorate existing assets and improve the efficiency of the use of funds, the company sold part of its shares in Xiamen Tebao Biological Engineering Co., Ltd. (688278.SH), resulting in a substantial increase in investment income, resulting in a significant increase in the company's net profit. At the same time, due to the decrease in operating income during the reporting period and the decline in gross profit margin after the price reduction of collected products, the company's net profit after deducting non-recurring profit and loss decreased accordingly compared with the same period last year.